Multicancer detection tests had sensitivity from 0.095 to 0.998, specificity from 0.657 to 1.0, and area under the receiver ...

Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...

A ratio-based tryptase formula for diagnosing pediatric anaphylaxis in the ED demonstrated higher diagnostic performance than ...

Multiple versions of ChatGPT demonstrated efficacy in identifying eligible patients for clinical trial recruitment, showing ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

Researchers have identified multiple causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD), ...

In oncology and cardiology, AI’s strength lies in deep learning techniques applied to imaging and genomic data. Convolutional ...

Early on-treatment liver stiffness measurements predict reduced risk for liver-related events in patients with CHB receiving antiviral therapy.

A meta-analysis of pediatric patients shows the potential promise of this noninvasive biomarker for early diagnosis, risk stratification, and management of nephrotic syndrome.

New research shows that incorporating dialysis status, eGFR, and proteinuria after induction enhances prediction of kidney ...

Greater baseline EASI scores and greater BMI are associated with poor response to lebrikizumab among patients with moderate to severe AD.

Discover how LAVImin measured by cardiac MRI outperformed traditional risk factors in predicting adverse outcomes after heart ...